These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Triptans and serotonin syndrome. Fine A; Bastings E Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550 [No Abstract] [Full Text] [Related]
3. Is an FDA alert harming patients? Schuman E JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393 [No Abstract] [Full Text] [Related]
4. From the editorial office. Rothrock JF Headache; 2012; 52(7):1069. PubMed ID: 22755549 [No Abstract] [Full Text] [Related]
5. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823 [TBL] [Abstract][Full Text] [Related]
6. The serotonin syndrome, triptans, and the potential for drug-drug interactions. Shapiro RE; Tepper SJ Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366 [TBL] [Abstract][Full Text] [Related]
8. Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessary. Horn JR; Hansten PD J Manag Care Pharm; 2011 Nov; 17(9):713. PubMed ID: 22050397 [No Abstract] [Full Text] [Related]
9. The dark side of SSRIs: selective serotonin reuptake inhibitors. Inott TJ Nurs Manage; 2009 Nov; 40(11):44-6. PubMed ID: 19901757 [No Abstract] [Full Text] [Related]
10. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Bonetto N; Santelli L; Battistin L; Cagnin A Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285 [No Abstract] [Full Text] [Related]
11. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning? Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629 [No Abstract] [Full Text] [Related]
13. In reference to Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Gillman K Laryngoscope; 2010 Feb; 120(2):436-7. PubMed ID: 19950381 [No Abstract] [Full Text] [Related]
14. The serotonin syndrome. Boyer EW; Shannon M N Engl J Med; 2005 Mar; 352(11):1112-20. PubMed ID: 15784664 [No Abstract] [Full Text] [Related]
15. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports. Evans RW MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054 [TBL] [Abstract][Full Text] [Related]
18. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome? Evans RW Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388 [No Abstract] [Full Text] [Related]
19. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say? Kogut SJ J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895 [TBL] [Abstract][Full Text] [Related]